Pacer Advisors, Inc. Bluebird Bio, Inc. Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$18.04 - $22.09 $43,440 - $53,192	-2,408 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$16.59 - $33.89 $11,579 - $23,655	-698 Reduced 22.47%	2,408 $73,000
Q4 2020 Jan 20, 2021	BUY	$27.5 - $37.92 $40,260 - $55,514	1,464 Added 89.16%	3,106 $134,000
Q3 2020 Oct 19, 2020	BUY	$34.44 - $43.75 $56,550 - $71,837	1,642 New	1,642 $89,000
Q4 2018 Feb 13, 2019	SELL	$59.1 - $93.26 $98,815 - $155,930	-1,672 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $148,573 - $196,443	1,672 New	1,672 $244,000
Q1 2018 May 14, 2018	SELL	$105.8 - $150.94 $95,220 - $135,846	-900 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $208,487 - $335,376	-2,566 Reduced 74.03%	900 $160,000
Q3 2017 Nov 08, 2017	BUY	$57.74 - $91.42 $200,126 - $316,861	3,466	3,466 $476,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.